Lets Learn The Right Use of PowerPoint

Lets Learn SomePowerPoint

Mohit Chhabra!mohit_chhabra

#pptevangelist

PowerPoint is Evil!

Sep 2003

Edward Tufte Data Visualization Pioneer Professor, Yale University

Ubiquitous

Class Room

RoomBoard

RoomWar

Necessary Evil

Evil

Container of Ideas

Shoot-the-Messenger Syndrome

PowerPointDeath by

&Best

WorstPresentations

WHY?WHY?

Lack of Preparation

PowerPointDeath by

PowerPointDeath by

Lets get active

What is a Presentation? !

Inform

Persuade

Entertain

Conversations

Persuade Inform

Persuade Inform

Persuade Inform

Text

TextVoice

TextVoice

TextVoice

Split Attention Effect

TextVoice

Split Attention Effect

PowerPoint Skills

PowerPoint Skills

PowerPoint Skills

Learning to create better graphics in PowerPoint for amplifying your

message

Complete sentence.3things

Subject. Learning to create better graphics3things

Verb. (Amplifying your message)

3things

WHY?WHY?

Audiences remember very few things

Data, Figures, Pictures, Text

Fragmented Retention

Big Idea

Strengthen

Graphs & Tables

Pictures

Diagrams

Progression

Graphs & Tables

US$ 0

US$ 1,50,000

US$ 3,00,000

US$ 4,50,000

US$ 6,00,000Ju

ly

Aug

ust

Sept

embe

r

Oct

ober

Nov

embe

r

Dec

embe

r

Pharma APharma BPharma CPharma DPharma EPharma FPharma GPharma HPharma I

Sales Compared to Competitors

0

150

300

450

600

0

150

300

450

600

July Aug Sep Oct Nov Dec July Aug Sep Oct Nov Dec

Pharma A Pharma D

Pharma G Pharma H

Note: All figures in $ ‘000

Sales Compared

0

150

300

450

600

0

150

300

450

600

July Aug Sep Oct Nov Dec July Aug Sep Oct Nov Dec

Pharma A Pharma D

Pharma G Pharma H

Note: All figures in $ ‘000

Average Pharma E

Sales Compared

0

150

300

450

600

0

150

300

450

600

A D G H E A D G H E A D G H E

Oct 2012 Nov 2012 Dec 2012

July 2012 Aug 2012 Sep 2012

Note: All figures in $ ‘000

Sales Compared

0

150

300

450

600

295

110

390

565

140

245

100

375

550

142

145

95

390390

153

0

150

300

450

600

A D G H E

255

90

385

570

188

A D G H E

190

80

460465

185

A D G H E

262

65

550570

200

Oct 2012 Nov 2012 Dec 2012

July 2012 Aug 2012 Sep 2012

Note: All figures in $ ‘000

Unable to Gain Traction

How much bigger is the large circle than the small circle?

16

Pharma HPharma GPharma F

Pharma E

Pharma D

Pharma C

Pharma B

Pharma A

Market Share

Pharma H 1%

Pharma G 4%Pharma F

7%

Pharma E 8%

Pharma D 10%

Pharma C 10%

Pharma B 28%

Pharma A 33%

Market Share

Market Share

Market Share at the end of 2012

A

Our Co.

C

D

E

F

G

H 1

4

7

8

10

10

28

33

Note: All figures in percent

Market Share at the end of 2012

A

Our Co.

C

D

E

Others

Note: All figures in percent

73%

Purpo

se

Analyzing

Purpo

se

Analyzing

Monitoring

Purpo

se

Analyzing

Monitoring

Purpo

sePlanning

Analyzing

Monitoring

Purpo

sePlanning

Communicating

What would you like to show?

What would you like to show?

Distribution

What would you like to show?

Distribution

Composition

What would you like to show?

Distribution

Relationship

Composition

What would you like to show?

Distribution

Relationship

CompositionComparison

Select the appropriate statistical data

‣ To show composition, usually

‣ To show composition, usually

‣ 4 – 6 slices

‣ To show composition, usually !

‣ 4 – 6 slices !

‣ Contrast with color or by exploding (or both!)

‣ To show comparison

‣ To show comparison

‣ Best used for a few periods of time

‣ To show comparison

‣ Best used for a few periods of time

‣ Best if you limit the bars to 4-6

Used to demonstrate trends

‣ To show comparison

‣ To show comparison

Rs

  Year 1 Year 2 Year 3

REVENUES 4,02,66,240 4,40,02,560 4,69,32,480

     EXPENSES      

Manpower 1,24,92,000 1,37,41,200 1,51,15,320

Total Operating Expenses 53,12,400 1,18,28,840 1,25,07,204

Depreciation 18,24,000 10,94,400 6,56,640

Software cost amortized 2,95,50,000 0 0

Total 4,91,78,400 2,66,64,440 2,82,79,164

Losses carried forward   -89,12,160  

EBIT -89,12,160 84,25,960 1,86,53,316

Manpower (%age) 31% 31% 32%

EBIT (%age) -22% 19% 40%

Rs

  Year 1 Year 2 Year 3

REVENUES 4,02,66,240 4,40,02,560 4,69,32,480

     EXPENSES      

Manpower 1,24,92,000 1,37,41,200 1,51,15,320

Total Operating Expenses 53,12,400 1,18,28,840 1,25,07,204

Depreciation 18,24,000 10,94,400 6,56,640

Software cost amortized 2,95,50,000 0 0

Total 4,91,78,400 2,66,64,440 2,82,79,164

Losses carried forward   -89,12,160  

EBIT -89,12,160 84,25,960 1,86,53,316

Manpower (%age) 31% 31% 32%

EBIT (%age) -22% 19% 40%

!

!

Too Detailed! !

Rs (lakh)

  Year 1 Year 2 Year 3

REVENUES 403 440 469

       EXPENSES      

Manpower 125 137 151

Total Operating Expenses 53 118 125

Depreciation 18 11 7

Software cost amortised 296 0 0

Total 492 267 283

Losses carried forward   -89  

EBIT -89 84 187

Manpower (as a %age) 31% 31% 32%

EBIT (as a %age) -22% 19% 40%

Rs (lakh)

  Year 1 Year 2 Year 3

REVENUES 403 440 469

       EXPENSES      

Manpower 125 137 151

Total Operating Expenses 53 118 125

Depreciation 18 11 7

Software cost amortised 296 0 0

Total 492 267 283

Losses carried forward   -89  

EBIT -89 84 187

Manpower (as a %age) 31% 31% 32%

EBIT (as a %age) -22% 19% 40%

!

!

Much Better! !

Rs (lakh)

  Year 1 Year 2 Year 3

REVENUES 403 440 469

       EXPENSES      

Manpower 125 137 151

Total Operating Expenses 53 118 125

Depreciation 18 11 7

Software cost amortised 296 0 0

Total 492 267 283

Losses carried forward   -89  

EBIT -89 84 187

Manpower (as a %age) 31% 31% 32%

EBIT (as a %age) -22% 19% 40%

When the numbers are more important than the relationship

!

!

Much Better! !

Data should be stripped to the

ESSENTIALS

Revenue This QuarterVa

lue

In R

s la

kh

0

83

167

250

333

417

500

Product

Supra Microg Gemna Hylar Elexso

190

80

460465

185

SupraMicrogGemnaHylarElexso

Revenue This QuarterVa

lue

In R

s la

kh

0

83

167

250

333

417

500

Product

Supra Microg Gemna Hylar Elexso

190

80

460465

185

SupraMicrogGemnaHylarElexso

Revenue This QuarterVa

lue

In R

s la

kh

0

83

167

250

333

417

500

Product

Supra Microg Gemna Hylar Elexso

190

80

460465

185

SupraMicrogGemnaHylarElexso

Revenue This QuarterVa

lue

In R

s la

kh

0

83

167

250

333

417

500

Product

Supra Microg Gemna Hylar Elexso

190

80

460465

185

SupraMicrogGemnaHylarElexso

Revenue This QuarterVa

lue

In R

s la

kh

0

83

167

250

333

417

500

Product

Supra Microg Gemna Hylar Elexso

190

80

460465

185

Revenue This QuarterVa

lue

In R

s la

kh

0

83

167

250

333

417

500

Supra Microg Gemna Hylar Elexso

190

80

460465

185

Revenue This Quarter

0

83

167

250

333

417

500

Supra Microg Gemna Hylar Elexso

190

80

460465

185

Revenue This Quarter

Supra Microg Gemna Hylar Elexso

190

80

460465

185

Revenue This Quarter

Supra Microg Gemna Hylar Elexso

190

80

460465

185

Revenue This Quarter

Supra Microg Gemna Hylar Elexso

190

80

460465

185

Revenue This Quarter

Supra Microg Gemna Hylar Elexso

190

80

460465

185

Revenue This Quarter

Supra Microg Gemna Hylar Elexso

190

80

460465

185

Revenue This Quarter

Supra Microg Gemna Hylar Elexso

190

80

460465

185

Revenue This Quarter

Supra Microg Gemna Hylar Elexso

190

80

460465

185

Supra Microg Gemna Hylar Elexso

190

80

460465

185

Q3 ’13 Revenues (in Rs lakh)

Source: Internal

Recap

Removed backgrounds

Removed extra labels

Removed borders and lines

Removed shadows, colors and effects

Simplified labels and title

Revenue This QuarterVa

lue

In R

s la

kh

0

83

167

250

333

417

500

Product

Supra Microg Gemna Hylar Elexso

190

80

460465

185

SupraMicrogGemnaHylarElexso

Supra Microg Gemna Hylar Elexso

190

80

460465

185

Q3 ’13 Revenues (in Rs lakh)

Source: Internal

Data to Inkratio

Data to Inkratio

INCREASE

Pictures

Lasting Partnerships

Partnerships Against All Odds

Text

Security!

Diagrams

1 Network

1 Network

1 Network

2 Segment

2 Segment

3 Flow

3 Flow

3 Flow

3 Flow

4 Join

4 Join

5 Stack

5 Stack

5 Stack

Progression

Revenue This QuarterVa

lue

In R

s la

kh

0

83

167

250

333

417

500

Product

Supra Microg Gemna Hylar Elexso

190

80

460465

185

SupraMicrogGemnaHylarElexso

Supra Microg Gemna Hylar Elexso

190

80

460465

185

Q3 ’13 Revenues (in Rs lakh)

Source: Internal

15 slides

Disruptive Technology

Time

Perf

orm

ance

Sustaining Technology

Performance improvement demanded

t

Performance Oversupply

Current performance of potentially disruptive technologyExpected tra

jectory of improvement

The sustaining technology has been disrupted

Disruptive Technology

Time

Perf

orm

ance

Sustaining Technology

Performance improvement demanded

t

Performance Oversupply

Current performance of potentially disruptive technologyExpected tra

jectory of improvement

The sustaining technology has been disrupted

Too

Cluttered

Disruptive Technology

Time

Perf

orm

ance

Disruptive Technology

Time

Perf

orm

ance

Disruptive Technology

Time

Perf

orm

ance

Sustaining Technology

Disruptive Technology

Time

Perf

orm

ance

Sustaining Technology

Disruptive Technology

Time

Perf

orm

ance

Sustaining Technology

Performance improvement demanded

Disruptive Technology

Time

Perf

orm

ance

Disruptive Technology

Time

Perf

orm

ance

t

Disruptive Technology

Time

Perf

orm

ance

t

Performance Oversupply

Disruptive Technology

Time

Perf

orm

ance

t

Disruptive Technology

Time

Perf

orm

ance

t

Disruptive Technology

Time

Perf

orm

ance

t

Current performance of potentially disruptive technology

Disruptive Technology

Time

Perf

orm

ance

t

Disruptive Technology

Time

Perf

orm

ance

t

Disruptive Technology

Time

Perf

orm

ance

t

Expected trajectory of im

provement

Disruptive Technology

Time

Perf

orm

ance

t

Disruptive Technology

Time

Perf

orm

ance

t

The sustaining technology has been disrupted

This is Tom Peters and he is very intelligent!

Tom Peters

You can use his quotes in your presentations!

Is it Actionable?

Is it Actionable? N

O

O DELETE it!

O DELETE it!Archive it!

DELETE it!Archive it!

O

Is it Actionable? N

Is it Actionable?

YES

.

.DEFER it!

.DEFER it!

DELEGATE it!

.

DELEGATE it!

.

.DO it!

.DO it!

Immediately

.DO it!

Immediately

To Do List

mohitchhabra

mohit_chhabra

mohitchhabra@gmail.com

mohitchhabra

"

!

!@